• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于潜伏性结核感染化疗的实验模型,尤其涉及利福平。

An experimental model of chemotherapy on dormant tuberculous infection, with particular reference to rifampicin.

作者信息

Kondo E, Kanai K

机构信息

Department of Cellular Immunology, National Institute of Health, Tokyo.

出版信息

Jpn J Med Sci Biol. 1988 Apr;41(2):37-47. doi: 10.7883/yoken1952.41.37.

DOI:10.7883/yoken1952.41.37
PMID:3149354
Abstract

Mice were infected intravenously with a streptomycin (SM)-dependent strain of tubercle bacilli which had been starved of the antibiotic. The inoculum persisted in the spleen for a fairly long period, especially keeping almost the initial level of viable counts in the first few weeks. Isoniazid (INH) administration exerted little effect on such fate of the infection at a bactericidal dose to the same strain multiplying under the supply of SM. Rifampicin (RFP) was, however, highly effective in either case. Similar results were obtained in the corresponding in vitro experiments. The data suggest that this animal model is a convenient system for screening drugs effective on the dormant tuberculous infection.

摘要

用一株已停用抗生素的链霉素(SM)依赖型结核杆菌静脉感染小鼠。接种物在脾脏中持续存在相当长一段时间,尤其是在最初几周内几乎保持初始活菌数水平。在对在SM供应下繁殖的同一菌株具有杀菌剂量的情况下,给予异烟肼(INH)对这种感染的命运几乎没有影响。然而,利福平(RFP)在两种情况下都非常有效。在相应的体外实验中也得到了类似的结果。数据表明,这种动物模型是筛选对潜伏性结核感染有效的药物的便利系统。

相似文献

1
An experimental model of chemotherapy on dormant tuberculous infection, with particular reference to rifampicin.关于潜伏性结核感染化疗的实验模型,尤其涉及利福平。
Jpn J Med Sci Biol. 1988 Apr;41(2):37-47. doi: 10.7883/yoken1952.41.37.
2
Drug resistance in newly discovered untreated tuberculosis patients in Poland, 1974-1977.1974 - 1977年波兰新发现的未经治疗的肺结核患者的耐药性
Tubercle. 1979 Dec;60(4):233-7. doi: 10.1016/0041-3879(79)90004-7.
3
[Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].基于连续耐药检测结果观察的耐多药结核分枝杆菌出现的归因因素
Kekkaku. 1998 Jul;73(7):471-6.
4
Comparison of the antituberculous activity of morphazinamide and pyrazinamide on chronic experimental tuberculosis. II. The emergence of resistance and its retardation in the course of monotherapy and combinations of antituberculous drugs.吗啉酰肼与吡嗪酰胺对慢性实验性结核病抗结核活性的比较。II. 单药治疗及抗结核药物联合治疗过程中耐药性的出现及其延缓情况。
Chemotherapia (Basel). 1964;9(3):168-75. doi: 10.1159/000220357.
5
[Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].[包括异烟肼(INH)和利福平(RFP)在内的抗结核药物所致粒细胞缺乏症——4例报告及文献复习]
Kekkaku. 2003 Nov;78(11):683-9.
6
Comparison of the antituberculous activity of morphazinamide and pyrazinamide on chronic experimental tuberculosis. I. The antimycobacterial efficacy made in vitro and in vivo.吗啉酰肼与吡嗪酰胺对慢性实验性结核病抗结核活性的比较。I. 体内外抗分枝杆菌疗效
Chemotherapia (Basel). 1964;9(3):158-67. doi: 10.1159/000220356.
7
Primary antituberculosis drug resistance and acquired rifampicin resistance in Gujarat, India.印度古吉拉特邦的原发性耐结核病及获得性利福平耐药情况。
Tubercle. 1988 Mar;69(1):37-42. doi: 10.1016/0041-3879(88)90038-4.
8
Drug-resistant tuberculosis in Budapest.布达佩斯的耐药结核病
Int J Tuberc Lung Dis. 1998 Sep;2(9):732-5.
9
Investigation of Elimination Rate, Persistent Subpopulation Removal, and Relapse Rates of Mycobacterium tuberculosis by Using Combinations of First-Line Drugs in a Modified Cornell Mouse Model.在改良的康奈尔小鼠模型中使用一线药物组合对结核分枝杆菌的清除率、持续亚群清除及复发率的研究
Antimicrob Agents Chemother. 2016 Jul 22;60(8):4778-85. doi: 10.1128/AAC.02548-15. Print 2016 Aug.
10
Drug Resistance of Mouse Somatic Cells to Rifampicin in Experimental Tuberculosis.实验性结核病中小鼠体细胞对利福平的耐药性
Bull Exp Biol Med. 2021 May;171(1):53-55. doi: 10.1007/s10517-021-05171-x. Epub 2021 May 29.

引用本文的文献

1
Simple model for testing drugs against nonreplicating Mycobacterium tuberculosis.用于测试抗非复制分枝杆菌结核分枝杆菌药物的简单模型。
Antimicrob Agents Chemother. 2010 Oct;54(10):4150-8. doi: 10.1128/AAC.00821-10. Epub 2010 Aug 2.
2
Unique model of dormant infection for tuberculosis vaccine development.用于结核病疫苗研发的独特潜伏感染模型。
Clin Vaccine Immunol. 2006 Sep;13(9):1014-21. doi: 10.1128/CVI.00120-06.
3
Dormancy of Mycobacterium tuberculosis and latency of disease.结核分枝杆菌的休眠与疾病的潜伏
Eur J Clin Microbiol Infect Dis. 1994 Nov;13(11):908-14. doi: 10.1007/BF02111491.